SA
DFTX icon

Sanctuary Advisors’s Definium Therapeutics DFTX Stock Holding History

Sanctuary Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$541K Buy
11,502
+36
+0.3% +$890 ﹤0.01% 1925
2026
Q1 		$217K Buy
11,466
+749
+7% +$12.7K ﹤0.01% 2318
2025
Q4 		$144K Sell
10,717
-948
-8% -$11.7K ﹤0.01% 2320
2025
Q3 		$138K Buy
11,665
+4
+0% +$37 ﹤0.01% 2315
2025
Q2 		$75.7K Buy
11,661
+329
+3% +$2.16K ﹤0.01% 2287
2025
Q1 		$66.3K Buy
11,332
+330
+3% +$2.36K ﹤0.01% 2129
2024
Q4 		$78.4K Sell
11,002
-5,000
-31% -$34.4K ﹤0.01% 2332
2024
Q3 		$121K Buy
+16,002
New +$111K ﹤0.01% 2296

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sanctuary Advisors's DFTX Position: Q2 2026 in Review

Sanctuary Advisors increased its Definium Therapeutics (DFTX) stake by 0.31% in Q2 2026, buying an estimated $890 and bringing the position to 11,502 shares worth $541K. The position accounts for ﹤0.01% of the portfolio, ranked #1925.

Sanctuary Advisors first reported a position in DFTX in Q3 2024 and has held it in 8 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Sanctuary Advisors held 11,502 shares of Definium Therapeutics worth $541K as of Q2 2026.
  • Sanctuary Advisors bought 36 Definium Therapeutics shares in Q2 2026, an estimated $890.
  • Definium Therapeutics made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1925 holding.
  • Sanctuary Advisors first reported a position in Definium Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.